Ratiopharm Articles
European Commission clears planned acquisition of Ratiopharm by Teva, subject to conditions
4 August 2010
Canadian competition authority calls for Teva divestments to complete Ratiopharm acquisition
3 August 2010
Teva triumphs in battle for Ratiopharm, with a whopping 3.6 billion-euro offer seeing off Pfizer and Actavis
19 March 2010
Showing 1-3 of 3 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
